Evidence map›Paper›PMID 24875540›Full record

ArticleScientific reports2014

Characterisation of cytoplasmic DNA complementary to non-retroviral RNA viruses in human cells.

Akira Shimizu, Yoko Nakatani, Takako Nakamura, Atsushi Jinno-Oue, Osamu Ishikawa, Jef D Boeke, Yasuhiro Takeuchi, Hiroo Hoshino

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Small RNA-based antimicrobial immunity.Nature reviews. Immunology · 2019
    Review
  16. Review
  17. Intracellular Antiviral Immunity.Advances in virus research · 2018
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Akira Shimizu1] Department of Virology and Preventive Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, JAPAN [2] Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, JAPAN [3] MRC/UCL Centre for Medical Molecular Virology and Wohl Virion Centre, Division of Infection and Immunity, University College London, Gower Street, London WC1E 6BT, United Kingdom.
Yoko NakataniDepartment of Virology and Preventive Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, JAPAN.
Takako NakamuraDepartment of Virology and Preventive Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, JAPAN.
Atsushi Jinno-OueDepartment of Virology and Preventive Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, JAPAN.
Osamu IshikawaDepartment of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, JAPAN.
Jef D BoekeHigh Throughput Biology Centre, Johns Hopkins University School of Medicine, 733 N. Broadway/335 Broadway Research Building, Baltimore, Maryland, 21205, USA.
Yasuhiro TakeuchiMRC/UCL Centre for Medical Molecular Virology and Wohl Virion Centre, Division of Infection and Immunity, University College London, Gower Street, London WC1E 6BT, United Kingdom.
Hiroo HoshinoDepartment of Virology and Preventive Medicine, Gunma University Graduate School of Medicine, Maebashi, Gunma 371-8511, JAPAN.
Gunma University · JPJohns Hopkins University · USUniversity College London · GB

Funding

Training CoreP50GM107632 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BURNS, KATHLEEN H · 2013 to 2017
$10.0M
Medical Research Council G0900950NIGMS NIH HHS P50 GM107632
6 · The paper itself

Abstract

The synthesis and subsequent genomic integration of DNA that is complementary to the genomes of non-retroviral RNA viruses are rarely observed. However, upon infection of various human cell lines and primary fibroblasts with the vesicular stomatitis virus (VSV), we detected DNA complementary to the VSV RNA. The VSV DNA was detected in the cytoplasm as single-stranded DNA fully complementary to the viral mRNA from the poly(A) region to the 7-methyl guanosine cap. The formation of this DNA was cell-dependent. Experimentally, we found that the transduction of cells that do not produce VSV DNA with the long interspersed nuclear element 1 and their infection with VSV could lead to the formation of VSV DNA. Viral DNA complementary to other RNA viruses was also detected in the respective infected human cells. Thus, the genetic information of the non-retroviral RNA virus genome can flow into the DNA of mammalian cells expressing LINE-1-like elements.

Indexed as

Base SequenceCells, CulturedCytoplasmDNA, ComplementaryDNA, ViralFibroblastsHumansMolecular Sequence DataRetroviridaeVesicular StomatitisVirus IntegrationDNA, ComplementaryDNA, Viral

Identifiers

PMID24875540
PMCPMC4038843
OpenAlexW2009603499

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.